Cargando…

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours

OBJECTIVE: We aimed to determine the validity of two risk scores for patients with non-muscle invasive bladder cancer in different European settings, in patients with primary tumours. METHODS: We included 1,892 patients with primary stage Ta or T1 non-muscle invasive bladder cancer who underwent a t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vedder, Moniek M., Márquez, Mirari, de Bekker-Grob, Esther W., Calle, Malu L., Dyrskjøt, Lars, Kogevinas, Manoils, Segersten, Ulrika, Malmström, Per-Uno, Algaba, Ferran, Beukers, Willemien, Ørntoft, Torben F., Zwarthoff, Ellen, Real, Francisco X., Malats, Nuria, Steyerberg, Ewout W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048166/ https://www.ncbi.nlm.nih.gov/pubmed/24905984 http://dx.doi.org/10.1371/journal.pone.0096849

Ejemplares similares

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR
por: Dyrskjøt, L, et al.
Publicado: (2012)

The Use of Molecular Analyses in Voided Urine for the Assessment of Patients with Hematuria
por: Beukers, Willemien, et al.
Publicado: (2013)

Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients
por: Chan, Owen T.M., et al.
Publicado: (2017)

Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
por: Boman, Karolina, et al.
Publicado: (2013)

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
por: Mezheyeuski, Artur, et al.
Publicado: (2020)

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?
por: Beukers, Willemien, et al.
Publicado: (2012)

Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts
por: Andersson, Gustav, et al.
Publicado: (2014)

Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer
por: Valdés, Alberto, et al.
Publicado: (2021)

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
por: Zieger, Karsten, et al.
Publicado: (2009)

PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity
por: Furuya, Hideki, et al.
Publicado: (2022)

Selection of Microsatellite Markers for Bladder Cancer Diagnosis without the Need for Corresponding Blood
por: van Tilborg, Angela A. G., et al.
Publicado: (2012)

Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
por: Reinert, Thomas, et al.
Publicado: (2012)

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer
por: Kerzeli, Iliana K., et al.
Publicado: (2023)

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer
por: Laurberg, Jens Reumert, et al.
Publicado: (2014)

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2014)

Acceptance of Vaccinations in Pandemic Outbreaks: A Discrete Choice Experiment
por: Determann, Domino, et al.
Publicado: (2014)

Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment
por: de Bekker-Grob, Esther W., et al.
Publicado: (2015)

Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder
por: Herbsleb, Malene, et al.
Publicado: (2008)

CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis
por: Masson-Lecomte, Alexandra, et al.
Publicado: (2019)

Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis
por: Pineda, Silvia, et al.
Publicado: (2014)

Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer
por: Pineda, Silvia, et al.
Publicado: (2015)

Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells
por: Herbsleb, Malene, et al.
Publicado: (2008)

Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs
por: Jensen, Steffen G, et al.
Publicado: (2011)

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2015)

Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
por: Kerzeli, Iliana K., et al.
Publicado: (2021)

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
por: Egerod, Frederikke Lihme, et al.
Publicado: (2009)

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
por: Lindskrog, Sia Viborg, et al.
Publicado: (2021)

Are microRNAs located in genomic regions associated with cancer?
por: Lamy, P, et al.
Publicado: (2006)

Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer
por: Nordentoft, Iver, et al.
Publicado: (2011)

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer
por: Nordentoft, Iver, et al.
Publicado: (2012)

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
por: Kristensen, Helle, et al.
Publicado: (2016)

Gene expression profiling of noninvasive primary urothelial tumours using microarrays
por: Aaboe, M, et al.
Publicado: (2005)

Clinical prediction models: a practical approach to development, validation, and updating
por: Steyerberg, Ewout W
Publicado: (2019)

Clinical prediction models: a practical approach to development, validation, and updating
por: Steyerberg, Ewout W
Publicado: (2009)

Clinical prediction models : a practical approach to development, validation, and updating /
por: Steyerberg, Ewout W.
Publicado: (2009)

Comparative analysis of discrete exosome fractions obtained by differential centrifugation
por: Jeppesen, Dennis K., et al.
Publicado: (2014)

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma
por: Dyrskjøt, L, et al.
Publicado: (2012)

What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment
por: van Egmond, Sven, et al.
Publicado: (2021)

Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts
por: Brems-Eskildsen, Anne Sofie, et al.
Publicado: (2010)

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
por: Thomsen, Mathilde Borg Houlberg, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v3gk62nk71kv78r1fe9g0veg52